Verano Holdings (VRNO) Return on Capital Employed (2022 - 2026)
Verano Holdings (VRNO) reported Return on Capital Employed of 6.79% for Q1 2026, up 671.0% year-over-year from 0.88% in Q1 2025, and down 7.3% quarter-over-quarter from 6.32% in Q4 2025.
Verano Holdings (VRNO) Return on Capital Employed (2022 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 5 years of Return on Capital Employed data on file, last reported at 6.79% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 6.79%, up 671.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 6.79% (up 671.0% YoY), and the FY2025 annual result was 6.2%, up 594.0% from the prior year.
- Return on Capital Employed eased to 6.79% in Q1 2026 per VRNO's latest filing, from 6.32% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 4.41% in Q4 2023 and troughed at 14.16% in Q3 2025.
- A 5-year average of 4.96% and a median of 6.32% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed jumped 1244 bps in 2023, then tumbled 1737 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 8.03% in 2022, then surged by 155 bps to 4.41% in 2023, then tumbled by 376 bps to 12.15% in 2024, then soared by 48 bps to 6.32% in 2025, then slipped by 7 bps to 6.79% in 2026.
- Business Quant data shows VRNO's Return on Capital Employed at 6.79% in Q1 2026, 6.32% in Q4 2025, and 14.16% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Verano Holdings | - | - | 98.98 Mn | -6.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.79% |
| Dec 31, 2025 | -6.32% |
| Sep 30, 2025 | -14.16% |
| Jun 30, 2025 | -13.60% |
| Mar 31, 2025 | -13.50% |
| Dec 31, 2024 | -12.15% |
| Sep 30, 2024 | 2.55% |
| Jun 30, 2024 | 3.68% |
| Mar 31, 2024 | 3.87% |
| Dec 31, 2023 | 4.41% |
| Sep 30, 2023 | -5.13% |
| Jun 30, 2023 | -5.26% |
| Mar 31, 2023 | -6.86% |
| Dec 31, 2022 | -8.03% |
| Sep 30, 2022 | 2.95% |